No Additional Licenses. Except as expressly provided in this Agreement, nothing in this Agreement shall grant either Party any right, title or interest in and to the Know-How, Patents or other intellectual property rights of the other Party (either expressly or by implication or estoppel).
No Additional Licenses. Except as expressly provided in Sections 7.1, 7.2, and Article 11, nothing in this Agreement grants either Party any right, title or interest in and to the intellectual property rights of the other Party (either expressly or by implication or estoppel).
No Additional Licenses. The licenses granted in this Section 5 are the sole rights and licenses granted to Licensee and Licensee is provided no other rights or licenses to the Software during the Commercial Term except as expressly stated in this Section 5. In particular, Licensee is not permitted to reproduce or distribute the Software as part of a VAR, OEM, distributor, reseller, or similar arrangement. IF LICENSEE REQUIRES A LICENSE TO DISTRIBUTE THE SOFTWARE OR ANY LICENSEE WORK UNDER SUCH AN ARRANGEMENT, OR REQUIRES ANY ADDITIONAL RIGHTS TO THE SOFTWARE, LICENSEE MUST OBTAIN EXPRESS WRITTEN AUTHORIZATION FROM SDNCENTER.
No Additional Licenses. Except as expressly provided in Sections 7.1, 7.2 and 11.3, nothing shall grant either Party any right, title or interest in and to the intellectual property rights of the other Party (either expressly or by implication or estoppel). Neither Party has a license under the other Party’s Licensed Patents for activities outside the scope of the licenses granted, or for Patents, Information or Materials not within the scope of the licenses granted.
No Additional Licenses. MBC understands and acknowledges that ---------------------- InterTrust is licensing to MBC only certain limited rights to use InterTrust Technology, which are further limited in certain ways and with respect to certain fields of use (such as the performance of Clearinghouse Functions), subject to the terms and conditions herein. Thus, notwithstanding the generality of any other limitations or restrictions contained in this Agreement, MBC acknowledges and agrees that the licenses that may be granted under Sections 5.2 and 5.3 are the only licenses granted to MBC, and that no other licenses are granted, expressly, or by implication or estoppel, now or in the future. In particular, and without limitation, MBC acknowledges that it: (i) shall have no license to perform Clearinghouse Functions, or to authorize or assist others to perform Clearinghouse Functions, other than as expressly set forth in Section 5.2(b); (ii) shall have no license to distribute to any Person any software or hardware representation of InterTrust Technology other than the Application Software and/or Authorized Clearinghouse Software as provided herein; and (iii) shall have no right to enter into sublicenses other than as expressly set forth in Section 5.3.
No Additional Licenses. SSG understands and acknowledges that ---------------------- InterTrust is licensing to SSG only certain limited rights to use InterTrust Technology (including performing Clearinghouse Functions and sublicensing certain rights granted SSG) as described herein. Thus, notwithstanding the generality of any other provision herein, SSG acknowledges and agrees that the licenses granted under Sections 5.1 and 5.2 are the only licenses granted to SSG, and that no other licenses are granted, expressly, or by implication or estoppel, now or in the future. All rights not expressly granted to SSG under this Agreement are reserved and retained by InterTrust.
No Additional Licenses. Except as expressly provided in this Agreement, nothing in this Agreement shall grant either Party any right, title or interest in and to the Know-How, Patents or other intellectual property rights of the other Party (either expressly or by implication or estoppel). For the avoidance of doubt GNE shall not, during the Term or subsequently, have any right or license under the Immunocore Background IP or the Immunocore Foreground IP to discover, research, develop or commercialise any Compounds.
No Additional Licenses. Except for the express license granted in this Article 2, neither Party shall be granted any license (either express, implied or by estoppel to the Patents or Information Controlled by the other Party.
No Additional Licenses. Except as expressly provided in Sections 4.2, 7.1, 7.2, and Article 11, nothing in this Agreement grants either Party any right, title or interest in and to the intellectual property rights of an Party (either expressly or by implication or estoppel). For clarity, the licenses granted in Section 7.1 by Exelixis to BMS do not give BMS any right or license (a) to incorporate into any Product (e.g., as a combination product) any compound that is Controlled by Exelixis and that is not a Licensed Compound or (b) to perform any research that is directed to identifying, characterizing, developing or otherwise pursuing any Small Molecule Compound that is not a Licensed Compound. For clarity, the licenses granted in Section 11.5 by BMS to Exelixis do not give Exelixis any right or license (a) to incorporate into any Product (e.g., as a combination product) any compound that is Controlled by Exelixis and that is not a Reverted Compound or (b) to perform any research that is directed to identifying, characterizing, developing or otherwise pursuing any small molecule compound that is not a Reverted Compound.
No Additional Licenses. Except as expressly provided in this Agreement, nothing in this Agreement grants either Party any right, title or interest in and to the Know-How, Patents, or other intellectual property rights of the other Party (expressly, by implication or by estoppel). For clarity and without limiting the foregoing, Kite acknowledges and agrees that the licenses granted in Section 2.1(a) and Section 2.1(b) do not create (expressly, by implication or by estoppel) any right or license under any Patents, Know-How, or other intellectual property right (in each case that is Controlled by Alpine) to research, develop, manufacture, use, sell, offer for sale, have sold, distribute, import, export, or otherwise commercialize: (i) any product that comprises any Validated TIP and that is in the Alpine Field; (ii) any derivative or modification of any TIP (or any product comprising any such derivatives or modifications), except to the extent permitted in the Research Plan for Program TIPs; or (iii) any proprietary molecule of Alpine that is not a TIP (either as a single product or in combination with a Licensed Product).
